Javascript must be enabled to continue!
Evaluation of Losartan Usage in a Regional Hospital in Hong Kong
View through CrossRef
Objective: To determine whether losartan usage follows the hospital's guidelines in terms of indications and reasons for use and to assess the accuracy of physicians in completing the losartan usage monitoring forms. Design: Drug utilization survey. Setting: A major government hospital in Hong Kong. Participants: Inpatients or outpatients prescribed losartan for the first time. Intervention: Physicians were to complete a monitoring form with both indications and reasons for losartan use. Main Outcome Measures: The appropriateness of losartan prescribing was evaluated in terms of indications (for hypertension with impaired left-ventricular function or hypertension in diabetic patients with persistent proteinuria) and reasons for preferred use (previous intolerance to adverse effects of angiotensin-converting enzyme inhibitors). The accuracy of completed monitoring forms was also assessed. Results: Forty-eight patients were prescribed losartan since its addition to the hospital formulary through the end of the study period (September 1997-May 1998). A review of medical records (regardless of the information provided by the physicians on the monitoring forms) revealed that 39 patients (81.3%) were prescribed losartan for appropriate indications and that 22 (45.8%) were given losartan rather than angiotensin-converting enzyme inhibitors for appropriate reasons according to the guidelines. Both appropriate indications and reasons were met in only 15 patients (31.3%). Of the 48 monitoring forms that were collected, three (6.3%) were not completed. The concordance rate of information provided by the doctors and information from case notes was 61.5% for indications and 34.8% for reasons of preferred use. Conclusions: Adherence to the hospital's usage guidelines and accuracy of the monitoring forms were suboptimal. Considering the high cost of losartan and its potential for long-term use, more educational activities, better dissemination of information, and more frequent evaluation of the acceptability of recommended usage guidelines are warranted.
Title: Evaluation of Losartan Usage in a Regional Hospital in Hong Kong
Description:
Objective: To determine whether losartan usage follows the hospital's guidelines in terms of indications and reasons for use and to assess the accuracy of physicians in completing the losartan usage monitoring forms.
Design: Drug utilization survey.
Setting: A major government hospital in Hong Kong.
Participants: Inpatients or outpatients prescribed losartan for the first time.
Intervention: Physicians were to complete a monitoring form with both indications and reasons for losartan use.
Main Outcome Measures: The appropriateness of losartan prescribing was evaluated in terms of indications (for hypertension with impaired left-ventricular function or hypertension in diabetic patients with persistent proteinuria) and reasons for preferred use (previous intolerance to adverse effects of angiotensin-converting enzyme inhibitors).
The accuracy of completed monitoring forms was also assessed.
Results: Forty-eight patients were prescribed losartan since its addition to the hospital formulary through the end of the study period (September 1997-May 1998).
A review of medical records (regardless of the information provided by the physicians on the monitoring forms) revealed that 39 patients (81.
3%) were prescribed losartan for appropriate indications and that 22 (45.
8%) were given losartan rather than angiotensin-converting enzyme inhibitors for appropriate reasons according to the guidelines.
Both appropriate indications and reasons were met in only 15 patients (31.
3%).
Of the 48 monitoring forms that were collected, three (6.
3%) were not completed.
The concordance rate of information provided by the doctors and information from case notes was 61.
5% for indications and 34.
8% for reasons of preferred use.
Conclusions: Adherence to the hospital's usage guidelines and accuracy of the monitoring forms were suboptimal.
Considering the high cost of losartan and its potential for long-term use, more educational activities, better dissemination of information, and more frequent evaluation of the acceptability of recommended usage guidelines are warranted.
Related Results
JIT 2023 - Jornadas de Jóvenes Investigadores Tecnológicos
JIT 2023 - Jornadas de Jóvenes Investigadores Tecnológicos
Es un honor presentar este libro que compila los trabajos de investigación y desarrollo presentados en las Jornadas de Jóvenes Investigadores Tecnológicos (JIT) 2023. Este evento s...
Losartan Monotherapy vs Combination Regimens in IgA Nephropathy: A Systematic Review and Network Meta-analysis
Losartan Monotherapy vs Combination Regimens in IgA Nephropathy: A Systematic Review and Network Meta-analysis
Background: IgA nephropathy (IgAN) is a disorder in which Immunoglobulin A (IgA) antibodies build up, causing kidney damage. Losartan, an Angiotensin Receptor Blocker (ARB), has sh...
Challenges and opportunities of Chinese ports: the multi-faced perspectives
Challenges and opportunities of Chinese ports: the multi-faced perspectives
(English) In this thesis, challenges and opportunities of Chinese ports and shipping is investigated from the multi-faced perspectives, i.e., the challenges between ports in the ba...
A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension
A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension
Background: Candesartan is a relatively novel antihypertensive agent of the angiotensin receptor blocker (ARB). Several clinical trials have compared candesartan with losartan in t...
Special Administrative Region of Hong Kong
Special Administrative Region of Hong Kong
The Special Administrative Region of Hong Kong (HKSAR) was established in 1997 when China recovered sovereignty over Hong Kong following the terms set out in the 1984 Sino-British ...
Impact of Losartan on Portal hypertension and Liver Cirrhosis: A Systematic Review
Impact of Losartan on Portal hypertension and Liver Cirrhosis: A Systematic Review
Abstract
Background
Portal hypertension, a complication of chronic liver disease, results from elevated pressure between the po...
Losartan: A Pharmacotherapy in Cardiovascular Disease
Losartan: A Pharmacotherapy in Cardiovascular Disease
Background:
A recently published article confirmed that in 2019, around 523 million people suffered from cardiovascular disease (including 18.6 million deaths) worldwide. Losartan,...
The Role of the Clinical Pharmacist in A Case of Losartan-Induced Faintness and Dysarthria
The Role of the Clinical Pharmacist in A Case of Losartan-Induced Faintness and Dysarthria
Background: A common first-line antihypertensive the medication losartan has excellent absorption after being taken orally and undergoes extensive first-pass metabolic processes. L...

